EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic accuracy of PfHRP2-based malaria rapid diagnostic tests and antigenemia persistence in Kenyan children from a holoendemic region: implications for case management and surveillance

Sharley A Wasena, Clinton O Onyango, Shamim W Osata, Samuel B Anyona, Evans Raballah, Ivy Hurwitz, Philip D Seidenberg, Collins Ouma, Qiuying Cheng, Kristan A Schneider, Douglas J Perkins

Experimental Biology and Medicine · 22.05.2025 · 250

DOI: 10.3389/ebm.2025.10585 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Biology and Medicine, online erschienen am 22.05.2025. Verfasst von Sharley A Wasena und 10 weiteren Autor:innen. Beteiligte Einrichtung: University of New Mexico-Kenya Global Health Programs, Kisumu, Kenya. Hauptthemen laut MEDLINE: Antigens, Protozoan, Protozoan Proteins, Malaria, Falciparum, Diagnostic Tests, Routine. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malaria remains a significant cause of childhood morbidity and mortality, with Plasmodium falciparum Histidine-Rich Protein 2 ( Pf HRP2)-based malaria rapid diagnostic tests (mRDTs) widely used in endemic regions where microscopy is sometimes not feasible. While these tests offer high sensitivity, persistent Pf HRP2 antigenemia and gene deletions can cause false-positive and false-negative results, compromising their accuracy for malaria case management and surveillance. This study evaluated the diagnostic performance and antigen persistence of Pf HRP2-mRDTs using data from a longitudinal birth cohort of 750 children followed monthly from birth to 36 months in a holoendemic region of Kenya. Malaria diagnosis was performed using both microscopy and mRDTs, with a total of 15,006 clinical events recorded from 573 children between 2017 and 2023. Data from an independent acute febrile cohort of 937 children (<5 years) followed for 14 days was analyzed to validate the findings. The mRDT showed a high sensitivity of 97.27% but a moderate specificity of 65.00% in acute febrile illness, indicating frequent false-positive results. The positive predictive value was low (35.10%), suggesting that confirmatory testing is needed, while the negative predictive value was high (98.89%), reinforcing the reliability of mRDTs in ruling out malaria. Persistent Pf HRP2 antigenemia was observed, with a median antigen clearance time of 51.14 days, respectively. Higher initial parasite densities (>50,000/μL) were associated with a slower antigen decay rate ( p = 0.001), highlighting the challenge of interpreting positive mRDT results after treatment. Validation using the acute febrile cohort showed that mRDT specificity exceeded 95% at initial diagnosis and follow-up. Overall, Pf HRP2-based mRDTs remain valuable for frontline malaria diagnosis but are limited by antigen persistence, leading to false positives in follow-up testing. Where feasible, integration of confirmatory diagnostic methods, such as microscopy or molecular assays, could improve the performance of malaria case management and clinical decision making, particularly in high-transmission settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, ProtozoanProtozoan ProteinsMalaria, FalciparumDiagnostic Tests, RoutinePlasmodium falciparumHumansKenyaInfantChild, PreschoolMaleFemaleSensitivity and SpecificityInfant, NewbornCase ManagementLongitudinal StudiesRapid Diagnostic Tests

Stichwörter der Autor:innen

PfHRP2Plasmodium falciparumhistidine rich proteinmRDTmalaria diagnosis

Substanzen

Antigens, ProtozoanHRP-2 antigen, Plasmodium falciparumProtozoan Proteins

Autor:innen und Institutionen

  • University of New Mexico-Kenya Global Health Programs, Kisumu, Kenya.
  • Department of Biomedical Sciences and Technology, School of Public Health and Community Development, Maseno University, Maseno, Kenya.
  • Department of Medical Biochemistry, School of Medicine, Maseno University, Maseno, Kenya.
  • Department of Medical Laboratory Sciences, School of Public Health, Biomedical Sciences and Technology, Masinde Muliro University of Science and Technology, Kakamega, Kenya.
  • Center for Global Health, Department of Internal Medicine, University of New Mexico, Albuquerque, NM, United States.
  • Department of Emergency Medicine, School of Medicine, University of New Mexico, Albuquerque, NM, United States.

Förderung

  • FIC NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Wasena, S. A., Onyango, C. O., Osata, S. W., Anyona, S. B., Raballah, E., Hurwitz, I., Seidenberg, P. D., Ouma, C., Cheng, Q., Schneider, K. A., & Perkins, D. J. (2025). Diagnostic accuracy of PfHRP2-based malaria rapid diagnostic tests and antigenemia persistence in Kenyan children from a holoendemic region: implications for case management and surveillance. Experimental Biology and Medicine, 250. https://doi.org/10.3389/ebm.2025.10585

Vancouver

Wasena SA, Onyango CO, Osata SW, Anyona SB, Raballah E, Hurwitz I, et al. Diagnostic accuracy of PfHRP2-based malaria rapid diagnostic tests and antigenemia persistence in Kenyan children from a holoendemic region: implications for case management and surveillance. Experimental Biology and Medicine. 2025;250. doi:10.3389/ebm.2025.10585

BibTeX
@article{Wasena2025,
  author = {Wasena, Sharley A and Onyango, Clinton O and Osata, Shamim W and Anyona, Samuel B and Raballah, Evans and Hurwitz, Ivy and Seidenberg, Philip D and Ouma, Collins and Cheng, Qiuying and Schneider, Kristan A and Perkins, Douglas J},
  title = {Diagnostic accuracy of PfHRP2-based malaria rapid diagnostic tests and antigenemia persistence in Kenyan children from a holoendemic region: implications for case management and surveillance},
  journal = {Experimental Biology and Medicine},
  year = {2025},
  volume = {250},
  doi = {10.3389/ebm.2025.10585}
}
Kostenlos starten →